Literature DB >> 7150652

Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes.

G Rijksen, G E Staal, P J Beks, M Streefkerk, J W Akkerman.   

Abstract

The isozyme distribution, kinetic properties and intracellular localization of hexokinase (ADP:D-hexose-6-phosphotransferase, EC 2.7.1.1) were studied in erythrocytes, blood platelets, lymphocytes and granulocytes. Soluble and particulate fractions were separated by a rapid density centrifugation method after controlled digitonin-induced cell lysis. In lymphocytes and platelets the major part of total activity was particle-bound (78 and 88%, respectively). In granulocytes and erythrocytes most of the hexokinase activity was found in the cytosol. All cell types, except granulocytes, contain mainly the type I isozyme. Platelets contain only type I hexokinase, while in lymphocytes a minor amount of type III is present in the soluble fraction (less than 10% of total activity). The major constituent of granulocytes is type III hexokinase (70-80% of total activity), the remaining 20-30% is type I hexokinase. Erythrocytes contain a multibanded type I hexokinase. The substrate affinities of the type I hexokinase do not differ significantly between the different cell types or between soluble, bound and solubilized fractions. Only soluble hexokinase from lymphocytes shows a slightly decreased Km apparent for glucose (P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150652     DOI: 10.1016/0304-4165(82)90230-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency.

Authors:  M Magnani; L Chiarantini; V Stocchi; M Dachà; G Fornaini
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Authors:  Hyun Sik Jun; David A Weinstein; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2014-02-24       Impact factor: 22.113

3.  Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation.

Authors:  Trevor P Fidler; Elizabeth A Middleton; Jesse W Rowley; Luc H Boudreau; Robert A Campbell; Rhonda Souvenir; Trevor Funari; Nicolas Tessandier; Eric Boilard; Andrew S Weyrich; E Dale Abel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-29       Impact factor: 8.311

4.  PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.

Authors:  Elena A Federzoni; Peter J M Valk; Bruce E Torbett; Torsten Haferlach; Bob Löwenberg; Martin F Fey; Mario P Tschan
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

5.  Rabbit red blood cell hexokinase:intracellular distribution during reticulocytes maturation.

Authors:  M Magnani; V Stocchi; M Dachà; G Fornaini
Journal:  Mol Cell Biochem       Date:  1984-08       Impact factor: 3.396

6.  Restricted diffusion of tyrosine hydroxylase and phenylethanolamine N-methyltransferase from digitonin-permeabilized adrenal chromaffin cells.

Authors:  K L Kelner; K Morita; J S Rossen; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Hexokinase microheterogeneity in rabbit red blood cells and its behaviour during reticulocytes maturation.

Authors:  V Stocchi; M Magnani; G Piccoli; G Fornaini
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

8.  Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.

Authors:  Maria Veiga-da-Cunha; Nathalie Chevalier; Xavier Stephenne; Jean-Philippe Defour; Nicole Paczia; Alina Ferster; Younes Achouri; Joseph P Dewulf; Carole L Linster; Guido T Bommer; Emile Van Schaftingen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

9.  CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation.

Authors:  Elena A Federzoni; Magali Humbert; Bruce E Torbett; Gerhard Behre; Martin F Fey; Mario P Tschan
Journal:  Sci Rep       Date:  2014-03-03       Impact factor: 4.379

10.  Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis.

Authors:  Núria Planell; M Carme Masamunt; Raquel Franco Leal; Lorena Rodríguez; Miriam Esteller; Juan J Lozano; Anna Ramírez; Maria de Lourdes Setsuko Ayrizono; Claudio Saddy Rodrigues Coy; Ignacio Alfaro; Ingrid Ordás; Sudha Visvanathan; Elena Ricart; Jordi Guardiola; Julián Panés; Azucena Salas
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.